Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.18B |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$340M |
| 3 |
Coca-Cola
KO
|
+$280M |
| 4 |
NVIDIA
NVDA
|
+$274M |
| 5 |
iShares US Pharmaceuticals ETF
IHE
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$828M |
| 2 |
ABB
ABB Ltd
ABB
|
+$679M |
| 3 |
NextEra Energy
NEE
|
+$553M |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$231M |
| 5 |
PepsiCo
PEP
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30% |
| 2 | Financials | 12.45% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Healthcare | 9.87% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Movado Group
MOV
$841M
| $952K | ﹤0.01% |
31,582
| – | – |
|
702
Build-A-Bear
BBW
$462M
| $946K | ﹤0.01% |
41,152
| – | – |
|
703
Phillips 66
PSX
$81.4B
| $934K | ﹤0.01% |
7,012
-1,223
| -15% | -$146K |
|
704
SPDR Gold Trust
GLD
$141B
| $933K | ﹤0.01% |
4,879
-313
| -6% | -$57.4K |
|
705
A10 Networks
ATEN
$1.95B
| $921K | ﹤0.01% |
69,910
-9,918
| -12% | -$120K |
|
706
Entravision Communication
EVC
$1.1B
| $918K | ﹤0.01% |
220,143
-30,202
| -12% | -$119K |
|
707
Genpact
G
$5.76B
| $905K | ﹤0.01% |
26,074
-4,568
| -15% | -$158K |
|
708
Anika Therapeutics
ANIK
$287M
| $875K | ﹤0.01% |
38,620
-2,105
| -5% | -$43.6K |
|
709
Schwab US Large- Cap ETF
SCHX
$74.5B
| $870K | ﹤0.01% |
46,281
+1,083
| +2% | +$19K |
|
710
Celldex Therapeutics
CLDX
$3.28B
| $865K | ﹤0.01% |
21,812
+1,274
| +6% | +$37.5K |
|
711
iShares US Telecommunications ETF
IYZ
$1.26B
| $853K | ﹤0.01% |
37,498
+2,181
| +6% | +$46.8K |
|
712
Sutro Biopharma
STRO
$421M
| $843K | ﹤0.01% |
19,652
| – | – |
|
713
United Therapeutics
UTHR
$23.1B
| $842K | ﹤0.01% |
3,828
+209
| +6% | +$48.2K |
|
714
Fidelity MSCI Health Care Index ETF
FHLC
$3.36B
| $835K | ﹤0.01% |
12,913
-414
| -3% | -$25.3K |
|
715
Weyerhaeuser
WY
$18.4B
| $835K | ﹤0.01% |
24,002
+13,632
| +131% | +$424K |
|
716
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$463M
| $823K | ﹤0.01% |
+27,489
| New | +$777K |
|
717
iShares US & Intl High Yield Corp Bond ETF
GHYG
$199M
| $819K | ﹤0.01% |
+18,505
| New | +$781K |
|
718
Amdocs
DOX
$6.22B
| $811K | ﹤0.01% |
9,223
-1,799
| -16% | -$150K |
|
719
Mondelez International
MDLZ
$79.9B
| $810K | ﹤0.01% |
11,189
-2,187
| -16% | -$150K |
|
720
Philip Morris
PM
$295B
| $807K | ﹤0.01% |
8,573
-3,522
| -29% | -$324K |
|
721
Schwab International Equity ETF
SCHF
$68.7B
| $803K | ﹤0.01% |
43,464
-27,722
| -39% | -$481K |
|
722
KLA
KLAC
$259B
| $799K | ﹤0.01% |
13,740
+1,950
| +17% | +$101K |
|
723
Wabtec
WAB
$49.3B
| $794K | ﹤0.01% |
6,254
-96
| -2% | -$10.8K |
|
724
iShares TIPS Bond ETF
TIP
$14.5B
| $790K | ﹤0.01% |
7,346
+635
| +9% | +$66.4K |
|
725
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $788K | ﹤0.01% |
13,548
+196
| +1% | +$10.5K |
|
Similar funds
Ken Fisher's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Fisher held 1,269 positions worth $189B, up 7.3% from $176B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher withdrew a net $8.48B in Q4 2023, closing 288 positions and reducing 487 holdings. Its most notable exit was SIEMENS AKTIENGESELLSCHAFT ADS, an estimated $828M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Ken Fisher opened a new position in Veralto worth $93.6M.
- Ken Fisher's largest Q4 2023 buy was Veralto: 1,137,890 shares worth $93.6M.
- Ken Fisher added most to ExxonMobil in Q4 2023, an estimated $1.18B increase.
- Ken Fisher's biggest Q4 2023 reduction was NextEra Energy, cutting an estimated $553M.
- Ken Fisher fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q4 2023, selling an estimated $828M.
- Ken Fisher's ten largest holdings make up 31% of its $189B portfolio in Q4 2023.
- Ken Fisher opened 101 new positions and closed 288 in Q4 2023.
- Ken Fisher's portfolio value rose 7.3% quarter-over-quarter to $189B.
Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.